Stifel Maintains Buy on Astrana Health, Raises Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Craig Jones maintains a Buy rating on Astrana Health (NASDAQ:ASTH) and raises the price target from $48 to $60.
August 01, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Craig Jones maintains a Buy rating on Astrana Health and raises the price target from $48 to $60.
The Buy rating and increased price target from a reputable analyst at Stifel is likely to positively impact investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100